Measuring the quality of care for localized prostate cancer.

PURPOSE: We describe the current status of quality of care measurement for localized prostate cancer and provide a framework for preserving a leadership role for our specialty in this dynamic and controversial field.
MATERIALS AND METHODS: Basic methodological principles of quality of care assessment were reviewed. Several factors that suggest the potential for current variation in the quality of care for patients with localized prostate cancer, particularly those receiving active treatment, were then analyzed. Subsequently contemporary publications and investigations that comprise the current foundation of prostate cancer quality of care research were reviewed.
RESULTS: The foundation for much of the emerging research in prostate cancer quality of care assessment is based on the Donabedian structure-process-outcome paradigm. The RAND candidate quality indicators for localized prostate cancer were developed in this framework and they represent the first effort to systematically consider the measurement of quality as it relates to prostate cancer. The feasibility of applying the RAND quality indicators to clinical quality of care assessments has been demonstrated, although further modification and refinement of the indicator set are necessary prior to large-scale, population based implementation of these quality assessment measures. Moreover, future quality of care efforts must make the transition to primarily prospective or concurrent quality assessments, such that measures can be taken to modify the structure and/or process of care at the time of delivery or shortly thereafter.
CONCLUSIONS: Prostate cancer quality of care assessment represents a burgeoning domain of urological health services research. To date such initiatives have come from within and outside of our specialty. In the future such efforts are likely to expand and they may have a substantial impact on the clinical and administrative aspects of urological practice. As a result, urologists should maintain a leading role in efforts to further define of quality of care as it relates to prostate cancer and radical prostatectomy.